Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma

Am J Hematol. 2020 Jun;95(6):E146-E148. doi: 10.1002/ajh.25794. Epub 2020 Apr 8.

Authors

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
² Division of Pulmonary & Critical Care, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

PMID: 32233094
DOI: 10.1002/ajh.25794

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adoptive Transfer / adverse effects*
Humans
Lymphoma, Large B-Cell, Diffuse / therapy*
Male
Middle Aged
Neurotoxicity Syndromes / etiology*
Primary Dysautonomias / etiology*